Viewing Study NCT05155566


Ignite Creation Date: 2025-12-24 @ 4:40 PM
Ignite Modification Date: 2026-01-02 @ 4:27 PM
Study NCT ID: NCT05155566
Status: COMPLETED
Last Update Posted: 2024-01-26
First Post: 2021-12-09
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Treatment Patterns And Clinical Outcomes Among Patients in Latin America Receiving First Line Palbociclib Combinations For HR+/HER2- Advanced/Metastatic Breast Cancer In Real World Settings.
Sponsor: Pfizer
Organization: